From January 1, 2024 to March 31, 2024, the company has repurchased 5,198,975 shares, representing 0.42% for $400 million. With this, the company has completed the repurchase of 18,663,819 shares, representing 1.5% for $1,475.28 million under the buyback announced on February 25, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.88 USD | +1.29% | +5.10% | -16.21% |
14/05 | Transcript : Gilead Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM | |
09/05 | Declaration of Voting Results by Gilead Sciences | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.21% | 84.54B | |
+32.36% | 694B | |
+29.81% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.60% | 239B | |
-3.39% | 209B | |
+10.25% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.